China Industry Times
SEE OTHER BRANDS

Get your industries and services news from China

China-backed malaria plan anticipated to aid Cambodia

(MENAFN) According to reports, malaria projects backed by China are anticipated to assist Cambodia in achieving its goal of eliminating malaria by the end of 2025.

Siv Sovannaroth, head of the Technical Bureau and manager of the Malaria Program at Cambodia’s National Center for Parasitology, Entomology and Malaria Control, stated that China has been aiding Cambodia in malaria control for almost a decade through multiple initiatives.

"China has a long collaboration with our center through South-South cooperation, Mekong-Lancang Cooperation, and the Belt and Road Initiative," he told Xinhua.

He added that the partnership has concentrated on strengthening the malaria program’s capabilities through training and research, implementing a pilot Mass Drug Administration project in western Kampong Speu province, and conducting surveillance in regions most affected by malaria.

Sovannaroth noted that Cambodia reported only 37 local malaria cases from January to August 2025, representing a dramatic decline of nearly 90 percent compared with 335 cases during the same period last year.

MENAFN18082025000045017281ID1109941168

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions